EFHD2 and colitis: However, after challenging with 3% DSS, Efhd2-/- mice developed more exacerbated colitis, manifested with increased loss of body weight, higher disease activity index (DAI) score and reduced length of colons, compared with similarly treated WT littermate controls (Fig. 1d–f).